Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147543 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Julia Doroszkiewicz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Biomarkers, Microglia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.
Themen: Demenz
Abstract (Originalsprache)
Recent investigations implicate neuroinflammatory changes, including astrocyte and microglia activation, as crucial in the progression of Alzheimer’s disease (AD) Thus, we compared selected proteins reflecting neuroinflammatory processes to establish their connection to AD pathologies. Our study, encompassing 80 subjects with (n = 42) AD, (n = 18) mild cognitive impairment (MCI) and (n = 20) non-demented controls compares the clinical potential of tested molecules. Using antibody-based methods, we assessed concentrations of NGAL, CXCL-11, sTREM1, and sTREM2 in cerebrospinal fluid (CSF). Proinflammatory proteins, NGAL, and CXCL-11 reached a peak in the early stage of the disease and allowed for the identification of patients with MCI. Furthermore, the concentration of the anti-inflammatory molecule sTREM2 was highest in the more advanced stage of the disease and permitted differentiation between AD and non-demented controls. Additionally, sTREM2 was biochemically linked to tau and pTau in the AD group. Notably, NGAL demonstrated superior diagnostic performance compared to classical AD biomarkers in discriminating MCI patients from controls. These findings suggest that proteins secreted mainly through microglia dysfunction might play not only a detrimental but also a protective role in the development of AD pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80 Mölndal, Sweden.
- Department of Neurology, Jagiellonian University, 30-688 Cracow, Poland.
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Mölndal, Sweden.
- Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
- UK Dementia Research Institute at UCL, London WC1N 3AR, UK.
ORCID-Profile: Maciej Dulewicz, Barbara Mroczko
Förderung
- Medical University of Bialystok
Zitieren
APA
Doroszkiewicz, J., Kulczyńska-Przybik, A., Dulewicz, M., Mroczko, J., Borawska, R., Słowik, A., Zetterberg, H., Hanrieder, J., Blennow, K., & Mroczko, B. (2024). Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147543
Vancouver
Doroszkiewicz J, Kulczyńska-Przybik A, Dulewicz M, Mroczko J, Borawska R, Słowik A, et al. Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147543
BibTeX
@article{Doroszkiewicz2024,
author = {Doroszkiewicz, Julia and Kulczyńska-Przybik, Agnieszka and Dulewicz, Maciej and Mroczko, Jan and Borawska, Renata and Słowik, Agnieszka and Zetterberg, Henrik and Hanrieder, Jörg and Blennow, Kaj and Mroczko, Barbara},
title = {Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147543}
}
EUVIMED